We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.28M
2
ADP icon
Automatic Data Processing
ADP
+$2.29M
3
AMZN icon
Amazon
AMZN
+$1.57M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.47M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.22M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSBC.PRA
901
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$10.6K ﹤0.01%
400
– –
TEF
902
DELISTED
Telefonica
TEF
$10.5K ﹤0.01%
1,252
– –
TER icon
903
Teradyne
TER
$54.8B
$10.5K ﹤0.01%
350
– –
JHI
904
John Hancock Investors Trust
JHI
$114M
$10.5K ﹤0.01%
611
-1
-0.2% -$17
EMDV icon
905
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.13M
$10.5K ﹤0.01%
200
– –
TVRD
906
Tvardi Therapeutics
TVRD
$23.5M
$10.5K ﹤0.01%
19
– –
WRB icon
907
W.R. Berkley
WRB
$28B
$10.4K ﹤0.01%
506
– –
IART icon
908
Integra LifeSciences
IART
$1.54B
$10.4K ﹤0.01%
190
– –
BBWI icon
909
Bath & Body Works
BBWI
$4.01B
$10.3K ﹤0.01%
238
– –
OI icon
910
O-I Glass
OI
$1.39B
$10.2K ﹤0.01%
427
-9
-2% -$198
IUSB icon
911
iShares Core Universal USD Bond ETF
IUSB
$42.6B
$10.2K ﹤0.01%
+200
New +$10.2K
TUZ
912
DELISTED
PIMCO 1-3 Year U.S. Treasury Index Exchange-Traded Fund
TUZ
$10.1K ﹤0.01%
200
– –
ZBRA icon
913
Zebra Technologies
ZBRA
$12.4B
$10.1K ﹤0.01%
100
– –
EMHY icon
914
iShares JPMorgan EM High Yield Bond ETF
EMHY
$618M
$10K ﹤0.01%
+200
New +$10.1K
KLXI
915
DELISTED
KLX Inc.
KLXI
$10K ﹤0.01%
237
– –
XTNT icon
916
Xtant Medical Holdings
XTNT
$60.1M
$9.97K ﹤0.01%
1,259
– –
VLY icon
917
Valley National Bancorp
VLY
$7.93B
$9.94K ﹤0.01%
842
– –
APU
918
DELISTED
AmeriGas Partners, L.P.
APU
$9.94K ﹤0.01%
220
– –
RXI icon
919
iShares Global Consumer Discretionary ETF
RXI
$245M
$9.9K ﹤0.01%
100
– –
IGF icon
920
iShares Global Infrastructure ETF
IGF
$11B
$9.89K ﹤0.01%
225
-151
-40% -$6.6K
PWR icon
921
Quanta Services
PWR
$93.9B
$9.88K ﹤0.01%
300
– –
GIB icon
922
CGI
GIB
$13.9B
$9.8K ﹤0.01%
192
– –
HTZ
923
DELISTED
Hertz Global Holdings, Inc.
HTZ
$9.73K ﹤0.01%
974
– –
PII icon
924
Polaris
PII
$4.15B
$9.68K ﹤0.01%
105
-1
-0.9% -$86
DBRG icon
925
DigitalBridge
DBRG
$2.94B
$9.65K ﹤0.01%
171
-1
-0.6% -$54
35 36
37
38 39

Similar funds

PJB
Paul John Balson Marina Del Rey, California $486M AUM 78.12% 1-Year Est. Return
IVA
International Value Advisers $615M AUM 6.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.